Unconfigured Ad
Collapse
SEQanswers sponsors/vendors can post commercial content here with approval from admin. Please support our sponsors!
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
NGRL combines CTC analysis with cfDNA strategies to transform cancer detection and monitoring
by Bio-Rad Laboratories
Started by Bio-Rad Laboratories, 12-04-2025, 02:57 PM
|
3 responses
204 views
0 reactions
|
Last Post
|
||
|
Started by Bruker, 04-07-2025, 06:25 AM
|
3 responses
503 views
0 reactions
|
Last Post
by pekgio
06-07-2026, 10:46 PM
|
||
|
Started by PerkinElmer AG, 07-25-2019, 07:55 AM
|
1 response
8,434 views
0 reactions
|
Last Post
by cement_head
02-09-2026, 12:22 PM
|
||
|
Started by Bruker, 06-23-2025, 08:07 AM
|
1 response
660 views
0 reactions
|
Last Post
by David hoff
07-16-2025, 03:14 AM
|
||
|
Started by seqadmin, 12-10-2024, 08:04 AM
|
0 responses
184 views
0 reactions
|
Last Post
by seqadmin
12-10-2024, 08:04 AM
|
||
|
Started by seqadmin, 11-27-2024, 02:41 PM
|
0 responses
178 views
0 reactions
|
Last Post
by seqadmin
11-27-2024, 02:41 PM
|
||
|
Started by Novogene, 11-21-2024, 02:02 PM
|
0 responses
489 views
0 reactions
|
Last Post
by Novogene
11-21-2024, 02:02 PM
|
||
|
Started by Novogene, 11-01-2024, 10:13 AM
|
0 responses
259 views
0 reactions
|
Last Post
by Novogene
11-01-2024, 10:13 AM
|
||
|
Exploring the Power of Whole Genome Sequencing: A Beginner’s Guide to Long-read Sequencing
by Novogene
Started by Novogene, 10-21-2024, 05:49 PM
|
0 responses
371 views
0 reactions
|
Last Post
by Novogene
10-21-2024, 05:49 PM
|
||
|
Started by Novogene, 09-16-2024, 07:51 AM
|
0 responses
412 views
0 reactions
|
Last Post
by Novogene
09-16-2024, 07:51 AM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...-
Channel: Articles
09-01-2026, 05:41 AM -
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 09-09-2026, 12:14 PM
|
0 responses
14 views
0 reactions
|
Last Post
by SEQadmin2
09-09-2026, 12:14 PM
|
||
|
Started by SEQadmin2, 09-09-2026, 11:33 AM
|
0 responses
10 views
0 reactions
|
Last Post
by SEQadmin2
09-09-2026, 11:33 AM
|
||
|
Started by SEQadmin2, 09-03-2026, 10:22 AM
|
0 responses
26 views
0 reactions
|
Last Post
by SEQadmin2
09-03-2026, 10:22 AM
|